Amphastar Pharmaceuticals
AMPH
$41.11
Share price
0.69%
Change (1 day)
7.73%
Change (1 year)
Categories
Amphastar Pharmaceuticals (AMPH) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.87 B
According to Amphastar Pharmaceuticals's latest financial reports the company's total liabilities are $0.87 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Amphastar Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.87 B | 309.46% |
| 2022-12-31 | $0.21 B | -5.61% |
| 2021-12-31 | $0.22 B | 23.83% |
| 2020-12-31 | $0.18 B | 14.47% |
| 2019-12-31 | $0.15 B | 6.86% |
| 2018-12-31 | $0.14 B | 27.16% |
| 2017-12-31 | $0.11 B | 19.14% |
| 2016-12-31 | $98.48 M | 4.08% |
| 2015-12-31 | $94.62 M | -11.98% |
| 2014-12-31 | $0.10 B | 23.29% |
| 2013-12-31 | $87.2 M | 3.77% |
| 2012-12-31 | $84.03 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Tonix Pharmaceuticals TNXP | $18.44 M | -97.89% | 🇺🇸 USA |
 SCYNEXIS SCYX | $56.55 M | -93.53% | 🇺🇸 USA |
 Marinus Pharmaceuticals MRNS | $0.15 B | -82.35% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $23.3 M | -97.33% | 🇺🇸 USA |